PEPGEN INC. Investment Income, Interest
PEPGEN INC. (PEPG) reported Investment Income, Interest of $1.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- PEPGEN INC. investment income, interest for the quarter ending 2026-06-30 was $1.09M, a 29.81% increase year-over-year.
- PEPGEN INC. investment income, interest for the quarter ending 2026-03-31 was $1.25M, a 11.41% increase year-over-year.
- PEPGEN INC. investment income, interest for the quarter ending 2025-12-31 was $1.42M, a 2.81% decline year-over-year.
- PEPGEN INC. investment income, interest for the quarter ending 2025-09-30 was $634.00K, a 65.28% decline year-over-year.
- PEPGEN INC. investment income, interest for fiscal 2025 was $4.02M, a 43.76% decline from fiscal 2024.
- PEPGEN INC. investment income, interest for fiscal 2024 was $7.14M, a 11.59% increase from fiscal 2023.
- PEPGEN INC. investment income, interest for fiscal 2023 was $6.40M, a 129.14% increase from fiscal 2022.
- PEPGEN INC. investment income, interest for fiscal 2022 was $2.79M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.09M 10-Q · filed 2026-08-06 | $2.34M 10-Q · filed 2026-08-06 | $3.76M derived: sum of 3 quarters · filed 2026-08-06 | $4.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-12 | $2.67M derived: sum of 2 quarters · filed 2026-05-12 | $3.30M derived: sum of 3 quarters · filed 2026-05-12 | $4.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.05M derived: sum of 2 quarters · filed 2026-03-04 | $2.90M derived: sum of 3 quarters · filed 2026-08-06 | $4.02M 10-K · filed 2026-03-04 |
| 2025-09-30 | $634.00K 10-Q · filed 2025-11-12 | $1.48M derived: sum of 2 quarters · filed 2026-08-06 | $2.60M 10-Q · filed 2025-11-12 | $4.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $842.00K 10-Q · filed 2026-08-06 | $1.96M 10-Q · filed 2026-08-06 | $3.42M derived: sum of 3 quarters · filed 2026-08-06 | $5.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.12M 10-Q · filed 2026-05-12 | $2.58M derived: sum of 2 quarters · filed 2026-05-12 | $4.41M derived: sum of 3 quarters · filed 2026-05-12 | $6.53M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $3.29M derived: sum of 2 quarters · filed 2026-03-04 | $5.41M derived: sum of 3 quarters · filed 2026-03-04 | $7.14M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.83M 10-Q · filed 2025-11-12 | $3.95M derived: sum of 2 quarters · filed 2025-11-12 | $5.68M 10-Q · filed 2025-11-12 | $7.03M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.12M 10-Q · filed 2025-08-07 | $3.86M 10-Q · filed 2025-08-07 | $5.20M derived: sum of 3 quarters · filed 2025-08-07 | $6.78M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.74M 10-Q · filed 2025-05-08 | $3.08M derived: sum of 2 quarters · filed 2025-05-08 | $4.66M derived: sum of 3 quarters · filed 2025-05-08 | $6.34M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $2.92M derived: sum of 2 quarters · filed 2025-02-24 | $4.61M derived: sum of 3 quarters · filed 2025-02-24 | $6.40M 10-K · filed 2025-02-24 |
| 2023-09-30 | $1.58M 10-Q · filed 2024-11-07 | $3.26M derived: sum of 2 quarters · filed 2024-11-07 | $5.05M 10-Q · filed 2024-11-07 | $6.64M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.68M 10-Q · filed 2024-08-08 | $3.48M 10-Q · filed 2024-08-08 | $5.07M derived: sum of 3 quarters · filed 2024-08-08 | $6.01M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.79M 10-Q · filed 2024-05-14 | $3.38M derived: sum of 2 quarters · filed 2024-05-14 | $4.33M derived: sum of 3 quarters · filed 2024-05-14 | $4.58M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.59M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-29 | $2.53M derived: sum of 2 quarters · filed 2024-03-29 | $2.78M derived: sum of 3 quarters · filed 2024-03-29 | $2.79M 10-K/A · filed 2024-03-29 |
| 2022-09-30 | $943.00K 10-Q · filed 2023-11-08 | $1.19M derived: sum of 2 quarters · filed 2023-11-08 | $1.20M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $250.00K 10-Q · filed 2023-08-08 | $259.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |